These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3954731)

  • 41. Effect of desferrioxamine, rhodotorulic acid and cholylhydroxamic acid on transferrin and iron exchange with hepatocytes in culture.
    Baker E; Page M; Torrance J; Grady R
    Clin Physiol Biochem; 1985; 3(6):277-88. PubMed ID: 4075694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro.
    Jeremy JY; Kontoghiorghes GJ; Hoffbrand AV; Dandona P
    Biochem J; 1988 Aug; 254(1):239-44. PubMed ID: 3140797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Competition between deferiprone, desferrioxamine and other chelators for iron and the effect of other metals.
    Sheppard LN; Kontoghiorghes GJ
    Arzneimittelforschung; 1993 Jun; 43(6):659-63. PubMed ID: 8352819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxic activity of deferiprone, maltol and related hydroxyketones against human tumor cell lines.
    Yasumoto E; Nakano K; Nakayachi T; Morshed SR; Hashimoto K; Kikuchi H; Nishikawa H; Kawase M; Sakagami H
    Anticancer Res; 2004; 24(2B):755-62. PubMed ID: 15161023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of a novel combination of two oral chelators deferasirox/deferiprone over deferoxamine/deferiprone in severely iron overloaded young beta thalassemia major patients.
    Elalfy MS; Adly AM; Wali Y; Tony S; Samir A; Elhenawy YI
    Eur J Haematol; 2015 Nov; 95(5):411-20. PubMed ID: 25600572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deferoxamine-induced iron mobilization and redistribution of myocardial iron in cultured rat heart cells: studies of the chelatable iron pool by electron microscopy and Mössbauer spectroscopy.
    Shiloh H; Iancu TC; Bauminger ER; Link G; Pinson A; Hershko C
    J Lab Clin Med; 1992 Apr; 119(4):428-36. PubMed ID: 1583395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of iron chelators on labile iron and oxidative status of thalassaemic erythroid cells.
    Prus E; Fibach E
    Acta Haematol; 2010; 123(1):14-20. PubMed ID: 19923794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Myocyte damage and loss of myofibers is the potential mechanism of iron overload toxicity in congestive cardiac failure in thalassemia. Complete reversal of the cardiomyopathy and normalization of iron load by deferiprone.
    Kolnagou A; Michaelides Y; Kontos C; Kyriacou K; Kontoghiorghes GJ
    Hemoglobin; 2008; 32(1-2):17-28. PubMed ID: 18274979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A; Natsiopoulos K; Kleanthous M; Ioannou A; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: Effects of deferoxamine and deferiprone.
    Yatmark P; Morales NP; Chaisri U; Wichaiyo S; Hemstapat W; Srichairatanakool S; Svasti S; Fucharoen S
    Exp Toxicol Pathol; 2014 Sep; 66(7):333-43. PubMed ID: 24907196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoring the impaired cardiac calcium homeostasis and cardiac function in iron overload rats by the combined deferiprone and N-acetyl cysteine.
    Wongjaikam S; Kumfu S; Khamseekaew J; Chattipakorn SC; Chattipakorn N
    Sci Rep; 2017 Mar; 7():44460. PubMed ID: 28287621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orally active alpha-ketohydroxypyridine iron chelators: studies in mice.
    Kontoghiorghes GJ
    Mol Pharmacol; 1986 Dec; 30(6):670-3. PubMed ID: 3785144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Iron chelation therapy.
    Hoffbrand AV; Wonke B
    J Intern Med Suppl; 1997; 740():37-41. PubMed ID: 9350180
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of deferiprone and deferrioxamine for the treatment of transfusional iron overload in children with beta thalassemia major.
    Waheed N; Ali S; Butt MA
    J Ayub Med Coll Abbottabad; 2014; 26(3):297-300. PubMed ID: 25671931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined iron chelation therapy.
    Galanello R; Agus A; Campus S; Danjou F; Giardina PJ; Grady RW
    Ann N Y Acad Sci; 2010 Aug; 1202():79-86. PubMed ID: 20712777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years.
    Poggi M; Sorrentino F; Pugliese P; Smacchia MP; Daniele C; Equitani F; Terlizzi F; Guitarrini MR; Monti S; Maffei L; Losardo A; Pasin M; Toscano V
    Ann Hematol; 2016 Apr; 95(5):757-63. PubMed ID: 26957357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deferoxamine versus combined therapy for chelating liver, spleen and bone marrow iron in beta-thalassemic patients: a quantitative magnetic resonance imaging study.
    Drakonaki EE; Maris TG; Maragaki S; Klironomos V; Papadakis A; Karantanas AH
    Hemoglobin; 2010; 34(1):95-106. PubMed ID: 20113293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Removal of thallium by combining desferrioxamine and deferiprone chelators in rats.
    Amiri A; Fatemi SJ; Fatemi SN
    Biometals; 2007 Apr; 20(2):159-63. PubMed ID: 16927173
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Deferiprone: greater efficacy at depleting myocardial than hepatic iron?
    Richardson DR
    Lancet; 2002 Aug; 360(9332):501-2. PubMed ID: 12241649
    [No Abstract]   [Full Text] [Related]  

  • 60. Iron mobilization using chelation and phlebotomy.
    Flaten TP; Aaseth J; Andersen O; Kontoghiorghes GJ
    J Trace Elem Med Biol; 2012 Jun; 26(2-3):127-30. PubMed ID: 22565013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.